These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26088120)

  • 1. Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder.
    Sabioni P; Bertram J; Le Foll B
    Curr Pharm Des; 2015; 21(23):3306-10. PubMed ID: 26088120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.
    Welsh JW; Tretyak V; McHugh RK; Weiss RD; Bogunovic O
    Drug Alcohol Depend; 2018 Aug; 189():96-107. PubMed ID: 29906718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine dependence and its treatment with low dose flumazenil.
    Hood SD; Norman A; Hince DA; Melichar JK; Hulse GK
    Br J Clin Pharmacol; 2014 Feb; 77(2):285-94. PubMed ID: 23126253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System.
    Hulse G; Kelty E; Hood S; Norman A; Basso MR; Reece AS
    Curr Pharm Des; 2015; 21(23):3325-42. PubMed ID: 26088116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Off-label Treatments for Mental Health: Inappropriate or Unavoidable? A Special Issue to Help Get Through the Maze.
    Rolland B; Amad A
    Curr Pharm Des; 2015; 21(23):3274-5. PubMed ID: 26238988
    [No Abstract]   [Full Text] [Related]  

  • 6. [Benzodiazepines to people with substance abuse problems?].
    Waal H; Bramness JG
    Tidsskr Nor Laegeforen; 2010 Mar; 130(6):610-2. PubMed ID: 20349006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety.
    Laprevote V; Schwan R; Schwitzer T; Rolland B; Thome J
    Curr Pharm Des; 2015; 21(23):3298-305. PubMed ID: 26088109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepines revisited--will we ever learn?
    Lader M
    Addiction; 2011 Dec; 106(12):2086-109. PubMed ID: 21714826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregabalin for the discontinuation of long-term benzodiazepines use: an assessment of its effectiveness in daily clinical practice.
    Bobes J; Rubio G; Terán A; Cervera G; López-Gómez V; Vilardaga I; Pérez M
    Eur Psychiatry; 2012 May; 27(4):301-7. PubMed ID: 21334859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregabalin in the discontinuation of long-term benzodiazepines' use.
    Oulis P; Konstantakopoulos G; Kouzoupis AV; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kontoangelos KA; Papadimitriou GN
    Hum Psychopharmacol; 2008 Jun; 23(4):337-40. PubMed ID: 18348245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing Pattern of Sedative Use in Older Adults: A Population-Based Cohort Study.
    Iaboni A; Bronskill SE; Reynolds KB; Wang X; Rochon PA; Herrmann N; J Flint A
    Drugs Aging; 2016 Jul; 33(7):523-33. PubMed ID: 27241038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist substitution--a treatment alternative for high-dose benzodiazepine-dependent patients?
    Liebrenz M; Boesch L; Stohler R; Caflisch C
    Addiction; 2010 Nov; 105(11):1870-4. PubMed ID: 20456294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzodiazepine dependence and withdrawal: identification and medical management.
    Landry MJ; Smith DE; McDuff DR; Baughman OL
    J Am Board Fam Pract; 1992; 5(2):167-75. PubMed ID: 1575069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sense and Sensibility When Prescribing 'Off-Label' to Psychiatric Patients.
    Baldwin DS; Tiwari N; Gordon R
    Curr Pharm Des; 2015; 21(23):3276-9. PubMed ID: 26088118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings.
    Denis C; Fatséas M; Lavie E; Auriacombe M
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005194. PubMed ID: 16856084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABAB Agonists for the Treatment of Alcohol Use Disorder.
    Mirijello A; Caputo F; Vassallo G; Rolland B; Tarli C; Gasbarrini A; Addolorato G
    Curr Pharm Des; 2015; 21(23):3367-72. PubMed ID: 26088121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data.
    Gallo AT; Hulse G
    J Psychopharmacol; 2021 Mar; 35(3):211-220. PubMed ID: 33426982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benzodiazepine withdrawal with carbamazepine].
    Kaendler SH; Volk S; Pflug B
    Nervenarzt; 1996 May; 67(5):381-6. PubMed ID: 9005346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence.
    Tamburin S; Faccini M; Casari R; Federico A; Morbioli L; Franchini E; Bongiovanni LG; Lugoboni F
    J Psychopharmacol; 2017 Oct; 31(10):1369-1373. PubMed ID: 28613124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive treatment of benzodiazepine discontinuation syndromes: a review.
    Roy-Byrne PP; Sullivan MD; Cowley DS; Ries RK
    J Psychiatr Res; 1993; 27 Suppl 1():143-53. PubMed ID: 7908331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.